Africa and the Middle East
Australia and New Zealand
Central and South America and the Caribbean
More than 1,200 biotech companies are located in the UK, and these companies are currently developing 900 biopharmaceutical products.
This trend is driving demand for medical equipment and injectable insulin.
The UK industry is the largest in Europe and second-largest in the world.
Wisconsin companies can get involved in plans to use artificial intelligence and data analysis to better understand rare diseases.
Longer lifespans and increased expectations for quality of life are driving continued growth.
The agency is also making plans for possible Brexit scenarios.
The country is a medical device hub for Central and South America, but is reliant on imports since it has no domestic production of these devices.
In particular, devices and supplies for retirement homes are needed.
Hospitalar is the largest medical industry fair in Latin America and the third-largest in the world.
The Costa Rican government recognizes approval by the U.S. Food and Drug Administration, streamlining the path for U.S. exports into the market.
These hospitals will need equipment and supplies, and the country imports the majority of its medical technology, creating opportunities for Wisconsin exporters.
Growth in these sectors is being driven by an aging population, increasing incidence of chronic and degenerative diseases, and changing lifestyle behaviors.
Wisconsin companies can provide the technologies to help Australia become a leading player in financial technology, precision agriculture, agribusiness, health care and senior care.
The UAE government is enacting policies and programs to help it become a hub for pharmaceuticals and is establishing medical research and development centers across the country.
The sector is experiencing double-digit growth that is expected to continue for at least the next five years.
Germany is home to more than 150 international trade fairs that attract up to 170,000 exhibitors and up to 10 million visitors annually.
Pharmaceuticals, travel and tourism, automotive parts, packaging and food processing equipment, printing and graphics, safety and security equipment, and renewable energy are the most promising industries for this growing market.
Despite concerns about Brexit's impact on the economy, the growth of this industry indicates it is still a solid area for investment.
The South American nation will be investing in urban roads, education, telecommunications, water resources and more.
The Middle Eastern nation has created the world's first Minister of Artificial Intelligence position, and both the public and private sectors are investing in AI research and development.
Approximately 10 percent of South Korea's growing elderly population is living with dementia.
This strong growth is creating opportunities for Wisconsin companies.
China's trade surplus with the U.S. is narrowing, and along with it, opportunities are rising for Wisconsin companies to export to China.
Trends including an aging population, growth in private health care, and increasing life expectancy are creating opportunities.
Hospitals and other health care facilities have room for improvement in the food they serve to patients, and Wisconsin companies can be part of the solution.
Wisconsin biotech companies with advanced technologies should consider partnering with South Korean companies.
The government has lifted restrictions on foreign direct investment in several key areas to help the sector grow to meet the needs of India's population.
A new government report emphasizes the importance of growth in innovative, high-tech products.
China's strength in the high-tech segment is still developing, and Wisconsin companies can help companies take products from concept to market.
Driven by a rise in dental tourism, dentists are investing in modern equipment, especially in urban areas--but lack of access to basic dental care is still a problem in rural areas.
Wisconsin companies can contribute to the spread of health technology, but should be aware of how the Canadian health care system differs from that of the U.S.
The industry continues to grow rapidly, driven primarily by pharmaceuticals, foods and beverages, and provides opportunities for Wisconsin companies.
The country is a distribution center within Europe for many companies, and has rising health care expenditures domestically as well as an ecosystem of research and development for innovations that make a worldwide impact.
With an aging population, Japan is looking to technology to help stem the increase in health care costs, and Wisconsin companies can supply some of these innovative devices.
Wisconsin research institutions and bioscience enterprises should consider collaborating with their Australian counterparts to conduct clinical trials due to the favorable conditions created by Australia’s regulatory, economic and health care systems.
With high prevalence of dementia in Australia, Wisconsin companies that provide services and technologies for elder care and dementia care can help meet growing demand.
The country aims to host 1.3 million medical tourists per year by 2021, and needs medical equipment to support the growing industry.
The country has one of Latin America's highest GDP growth rates, and serves as a hub for regional trade in addition to having strong domestic demand.
Affected sectors include mining, manufacturing, transportation, commercial services, finance, scientific research and culture.
The two countries are relaxing restrictions on trade of beef, chicken, liquefied natural gas, and financial services, among other categories.
Wisconsin health and medical product and service companies may find export opportunities with Jamaican hospitals, clinics and medical product distributors as demand grows to accommodate expansion of this sector.
Rising incomes, as well as rising health needs, are driving massive growth in the sector.
The 2010 lifting of a restriction opened the market to foreign entrants.
Domestic production is not keeping up with demand, creating opportunities for Wisconsin products and technologies.
Wisconsin exporters should take a closer look at these strong and growing sectors.
Opportunities for Wisconsin companies
Opportunities for Wisconsin exporters of medical devices and supplies
Renewable energy, medical technology and industrial machinery are sectors of particular promise.
Industrial machinery, medical equipment and food are key sectors of opportunity for Wisconsin companies in this market.
Opportunities for Wisconsin suppliers of diagnostic tests, reagents, medical products and insecticides
New guidelines call for a focus on industries such as information technology, advanced materials and biomedicine, as well as key upgrades to traditional manufacturing, such as smart processes, green manufacturing and safety improvements.
Canada offers a highly diversified, export-oriented medical device industry that manufactures equipment and supplies based on research and technology development. This market is estimated at just over $8 billion, with imports at approximately $6.7 billion and exports at $1.4 billion. Canada’s largest trading partner for medical devices is the U.S., and in 2015, medical device imports from the U.S. were estimated at just over $3 billion, representing 45 percent of Canada’s total medical device imports. Imports from Wisconsin were just over $48 million. The Canadian medical device market depends upon imports for about 80 percent of its consumption.
Opportunities for Wisconsin companies in pharmacology, food science, environmental issues, regenerative medicine and more
Business-friendly changes in sectors including health care and education spell opportunity for Wisconsin companies.
The market for medical technology and devices in the United Kingdom, around $9.6 billion in 2016, is the sixth-largest in the world. Business Monitor International expects a growth of 12.5 percent through 2019. Three-quarters of the demand is met by imports, providing opportunities for Wisconsin firms.
With growing incomes, the country will be working to bring the number of doctors and hospital beds up to global standards, and will need to rely on imports to fuel growth in many parts of the sector.
Advanced manufacturing; food and agribusiness; medical technologies and pharmaceuticals; mining equipment, technology and services; and oil, gas and energy have been identified as the priority sectors.
The Russian government offers subsidies to makers of medications on the essential drugs list, and Pfizer and Abbott Laboratories have already launched agreements with Russian partners to allow them to enter the market.
The world’s top location for trade shows, Germany hosts about 150 international trade fairs a year, attracting up to 170,000 exhibitors and up to 10 million visitors annually. These visitors and exhibitors spend $13.4 billion annually, boosting economic output by $26.2 billion.
The Life Sciences 2030 plan is an initiative from the HollandBIO association, and was established by leading companies and experts in this sector. According to HollandBIO, the Dutch life science sector comprised 455 companies with 24,000 employees in 2015, mostly in research and development. One of the goals for 2030 is to have 1,279 companies and over 60,000 employees active in this sector.
Mexico does not currently play a major role in clinical research, but because of its strategic importance, established infrastructure, and large population of potential research subjects, it could easily host many more clinical trials. In the past, cumbersome regulatory and quality issues discouraged the global pharmaceutical industry from conducting pivotal drug-approval studies in Mexico, but the situation is changing, and there is interest and potential to solve the issues standing in the way of studies by major pharmaceutical players.
Explore New Export Opportunities in Argentina and Chile ARGENTINA Situated in the southern hemisphere bordering Chile, Bolivia, Paraguay, Brazil and Uruguay, Argentina has a population of 43.4 million, 92 percent of whom live in urban areas. Despite two sovereign debt defaults in the last 15 years and the end of the commodity boom, Argentina presents significant long-term…
Market News Update Market: Italy Date: September 2015 Milan Expo: "Feeding the Planet, Energy for Life" Why this is important to Wisconsin businesses: Opportunities for companies in Wisconsin's food and agriculture sectors Industry/sector: Food and Beverage, Agriculture/Timber Alhough Expo Milano 2015, the globe’s largest exposition with an average of 20 million visitors, is almost over (it runs May 1…
Queensland is geographically the second-largest of Australia’s six states, occupying about 25 percent of the continent. Its population of 4.7 million is expected to increase to 6.1 million within 10 years, and most of this growth will occur in the southeast corner. Queensland has the most geographically dispersed
Singapore has built world-class infrastructure for bioscience research and development (R&D) and manufacturing, and has attracted and developed skilled talent for basic as well as translational research. Over the last 15 years, the sector has managed to attract R&D partnerships from major global players in the pharmaceutical and medical device segments. Today, the bioscience sector accounts for $1.1 billion in R&D expenditure and $225 billion in manufacturing outp
Market News Update Market: Germany Date: March 2015 Germany’s Increasing Strength in Wind Power Why this is important to Wisconsin businesses: A new cluster of startups in Germany seeks to exploit the digital revolution in the medical sector, creating new business opportunities. Industry/sector: Energy New figures from the European Wind Energy Association (EWEA) reveal that nearly 11.8GW of…
“Global Challenges, Smart Solutions” is the theme of the Netherlands delegation at Hannover Messe 2016. Dutch technology companies will show their pragmatic, inventive and strong interdisciplinary approach and their international cooperation toward solving challenges in water technology, energy, health care and food production.
Despite the political crisis affecting the Brazilian economy, some segments of the economy have shown growth and investment, including pharmaceuticals, beauty and cosmetics, IT innovation, textiles, agribusiness and renewable energy.
The United Arab Emirates’ (UAE’s) life sciences sector is fueled by opportunities for innovation. The sector’s size is growing rapidly, and is expected to reach $46 billion by 2019.